EndoChoice Q3 revenue up 30%, hits $13.4M: 5 key notes

EndoChoice reported 30 percent increase in third quarter revenue.

Here are five key notes on the company's financial report:

1. Revenue was up 30 percent to $18.4 million in the third quarter. Pathology revenue was up 23 percent.

2. International revenue grew 188 percent year-over-year and is now 12 percent of total revenue.

3. Gross profit hits $6.1 million, 33.4 percent over the same period last year.

4. Net loss for the quarter was $11.6 million, or $0.47 per share.

5. Total revenue is expected to reach $72 million to $74 million for the full year. Net loss is projected at$60 million to $61 million.

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months